More on: enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized cross‐over trial
Authors:
- 1 July 2006
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (7) , 1638-1639
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- P2Y12 receptor‐mediated potentiation of thrombin‐induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activationJournal of Thrombosis and Haemostasis, 2006
- Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trialJournal of Thrombosis and Haemostasis, 2005
- Effects of Clopidogrel and Aspirin in Combination Versus Aspirin Alone on Platelet Activation and Major Receptor Expression in Patients After Recent Ischemic StrokeStroke, 2005
- Polyamines Inhibit Both Platelet Aggregation and Glycoprotein IIb/IIIa ActivationJournal of Cardiovascular Pharmacology, 2005
- Aspirin resistance and a single geneThe American Journal of Cardiology, 2005
- Randomized clinical trial of the antiplatelet effects of aspirin–clopidogrel combination versus aspirin alone after lower limb angioplastyBritish Journal of Surgery, 2005
- Agonist Binding and Gq-Stimulating Activities of the Purified Human P2Y1 ReceptorMolecular Pharmacology, 2004
- Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphateThrombosis Research, 2002
- Aspirin and Platelets: The Antiplatelet Action of Aspirin and Its Role in Thrombosis Treatment and ProphylaxisSeminars in Thrombosis and Hemostasis, 1997
- Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitmentBlood, 1991